Table of Content

1 PD-1 and PD-L1 Drug Market Overview
1.1 PD-1 and PD-L1 Drug Product Overview
1.2 PD-1 and PD-L1 Drug Market Segment by Type
1.2.1 PD-1 Monoclonal Antibody
1.2.2 PD-L1 Monoclonal Antibody
1.3 Global PD-1 and PD-L1 Drug Market Size by Type
1.3.1 Global PD-1 and PD-L1 Drug Market Size Overview by Type (2024-2034)
1.3.2 Global PD-1 and PD-L1 Drug Historic Market Size Review by Type (2024-2024)
1.3.3 Global PD-1 and PD-L1 Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America PD-1 and PD-L1 Drug Sales Breakdown by Type (2024-2024)
1.4.2 Europe PD-1 and PD-L1 Drug Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific PD-1 and PD-L1 Drug Sales Breakdown by Type (2024-2024)
1.4.4 Latin America PD-1 and PD-L1 Drug Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa PD-1 and PD-L1 Drug Sales Breakdown by Type (2024-2024)
2 Global PD-1 and PD-L1 Drug Market Competition by Company
2.1 Global Top Players by PD-1 and PD-L1 Drug Sales (2024-2024)
2.2 Global Top Players by PD-1 and PD-L1 Drug Revenue (2024-2024)
2.3 Global Top Players by PD-1 and PD-L1 Drug Price (2024-2024)
2.4 Global Top Manufacturers PD-1 and PD-L1 Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 PD-1 and PD-L1 Drug Market Competitive Situation and Trends
2.5.1 PD-1 and PD-L1 Drug Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by PD-1 and PD-L1 Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in PD-1 and PD-L1 Drug as of 2022)
2.7 Date of Key Manufacturers Enter into PD-1 and PD-L1 Drug Market
2.8 Key Manufacturers PD-1 and PD-L1 Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 PD-1 and PD-L1 Drug Status and Outlook by Region
3.1 Global PD-1 and PD-L1 Drug Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global PD-1 and PD-L1 Drug Historic Market Size by Region
3.2.1 Global PD-1 and PD-L1 Drug Sales in Volume by Region (2024-2024)
3.2.2 Global PD-1 and PD-L1 Drug Sales in Value by Region (2024-2024)
3.2.3 Global PD-1 and PD-L1 Drug Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global PD-1 and PD-L1 Drug Forecasted Market Size by Region
3.3.1 Global PD-1 and PD-L1 Drug Sales in Volume by Region (2024-2034)
3.3.2 Global PD-1 and PD-L1 Drug Sales in Value by Region (2024-2034)
3.3.3 Global PD-1 and PD-L1 Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global PD-1 and PD-L1 Drug by Application
4.1 PD-1 and PD-L1 Drug Market Segment by Application
4.1.1 Liver Cancer
4.1.2 Esophageal Cancer
4.1.3 Nasal Cancer
4.1.4 Stomach Cancer
4.1.5 Other
4.2 Global PD-1 and PD-L1 Drug Market Size by Application
4.2.1 Global PD-1 and PD-L1 Drug Market Size Overview by Application (2024-2034)
4.2.2 Global PD-1 and PD-L1 Drug Historic Market Size Review by Application (2024-2024)
4.2.3 Global PD-1 and PD-L1 Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America PD-1 and PD-L1 Drug Sales Breakdown by Application (2024-2024)
4.3.2 Europe PD-1 and PD-L1 Drug Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific PD-1 and PD-L1 Drug Sales Breakdown by Application (2024-2024)
4.3.4 Latin America PD-1 and PD-L1 Drug Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa PD-1 and PD-L1 Drug Sales Breakdown by Application (2024-2024)
5 North America PD-1 and PD-L1 Drug by Country
5.1 North America PD-1 and PD-L1 Drug Historic Market Size by Country
5.1.1 North America PD-1 and PD-L1 Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America PD-1 and PD-L1 Drug Sales in Volume by Country (2024-2024)
5.1.3 North America PD-1 and PD-L1 Drug Sales in Value by Country (2024-2024)
5.2 North America PD-1 and PD-L1 Drug Forecasted Market Size by Country
5.2.1 North America PD-1 and PD-L1 Drug Sales in Volume by Country (2024-2034)
5.2.2 North America PD-1 and PD-L1 Drug Sales in Value by Country (2024-2034)
6 Europe PD-1 and PD-L1 Drug by Country
6.1 Europe PD-1 and PD-L1 Drug Historic Market Size by Country
6.1.1 Europe PD-1 and PD-L1 Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe PD-1 and PD-L1 Drug Sales in Volume by Country (2024-2024)
6.1.3 Europe PD-1 and PD-L1 Drug Sales in Value by Country (2024-2024)
6.2 Europe PD-1 and PD-L1 Drug Forecasted Market Size by Country
6.2.1 Europe PD-1 and PD-L1 Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe PD-1 and PD-L1 Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific PD-1 and PD-L1 Drug by Region
7.1 Asia-Pacific PD-1 and PD-L1 Drug Historic Market Size by Region
7.1.1 Asia-Pacific PD-1 and PD-L1 Drug Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific PD-1 and PD-L1 Drug Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific PD-1 and PD-L1 Drug Sales in Value by Region (2024-2024)
7.2 Asia-Pacific PD-1 and PD-L1 Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific PD-1 and PD-L1 Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific PD-1 and PD-L1 Drug Sales in Value by Region (2024-2034)
8 Latin America PD-1 and PD-L1 Drug by Country
8.1 Latin America PD-1 and PD-L1 Drug Historic Market Size by Country
8.1.1 Latin America PD-1 and PD-L1 Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America PD-1 and PD-L1 Drug Sales in Volume by Country (2024-2024)
8.1.3 Latin America PD-1 and PD-L1 Drug Sales in Value by Country (2024-2024)
8.2 Latin America PD-1 and PD-L1 Drug Forecasted Market Size by Country
8.2.1 Latin America PD-1 and PD-L1 Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America PD-1 and PD-L1 Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa PD-1 and PD-L1 Drug by Country
9.1 Middle East and Africa PD-1 and PD-L1 Drug Historic Market Size by Country
9.1.1 Middle East and Africa PD-1 and PD-L1 Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa PD-1 and PD-L1 Drug Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa PD-1 and PD-L1 Drug Sales in Value by Country (2024-2024)
9.2 Middle East and Africa PD-1 and PD-L1 Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa PD-1 and PD-L1 Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa PD-1 and PD-L1 Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Bristol Myers Squibb
10.1.1 Bristol Myers Squibb Company Information
10.1.2 Bristol Myers Squibb Introduction and Business Overview
10.1.3 Bristol Myers Squibb PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Bristol Myers Squibb PD-1 and PD-L1 Drug Products Offered
10.1.5 Bristol Myers Squibb Recent Development
10.2 Merck & Co., Inc.
10.2.1 Merck & Co., Inc. Company Information
10.2.2 Merck & Co., Inc. Introduction and Business Overview
10.2.3 Merck & Co., Inc. PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Merck & Co., Inc. PD-1 and PD-L1 Drug Products Offered
10.2.5 Merck & Co., Inc. Recent Development
10.3 F. Hoffmann -La Roche Ltd
10.3.1 F. Hoffmann -La Roche Ltd Company Information
10.3.2 F. Hoffmann -La Roche Ltd Introduction and Business Overview
10.3.3 F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2024-2024)
10.3.4 F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Products Offered
10.3.5 F. Hoffmann -La Roche Ltd Recent Development
10.4 AstraZeneca
10.4.1 AstraZeneca Company Information
10.4.2 AstraZeneca Introduction and Business Overview
10.4.3 AstraZeneca PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2024-2024)
10.4.4 AstraZeneca PD-1 and PD-L1 Drug Products Offered
10.4.5 AstraZeneca Recent Development
10.5 Sanofi
10.5.1 Sanofi Company Information
10.5.2 Sanofi Introduction and Business Overview
10.5.3 Sanofi PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Sanofi PD-1 and PD-L1 Drug Products Offered
10.5.5 Sanofi Recent Development
10.6 Pfizer Inc
10.6.1 Pfizer Inc Company Information
10.6.2 Pfizer Inc Introduction and Business Overview
10.6.3 Pfizer Inc PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Pfizer Inc PD-1 and PD-L1 Drug Products Offered
10.6.5 Pfizer Inc Recent Development
10.7 Lilly
10.7.1 Lilly Company Information
10.7.2 Lilly Introduction and Business Overview
10.7.3 Lilly PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Lilly PD-1 and PD-L1 Drug Products Offered
10.7.5 Lilly Recent Development
10.8 Novartis AG
10.8.1 Novartis AG Company Information
10.8.2 Novartis AG Introduction and Business Overview
10.8.3 Novartis AG PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Novartis AG PD-1 and PD-L1 Drug Products Offered
10.8.5 Novartis AG Recent Development
10.9 GSK
10.9.1 GSK Company Information
10.9.2 GSK Introduction and Business Overview
10.9.3 GSK PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2024-2024)
10.9.4 GSK PD-1 and PD-L1 Drug Products Offered
10.9.5 GSK Recent Development
10.10 Junshi Biosciences
10.10.1 Junshi Biosciences Company Information
10.10.2 Junshi Biosciences Introduction and Business Overview
10.10.3 Junshi Biosciences PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Junshi Biosciences PD-1 and PD-L1 Drug Products Offered
10.10.5 Junshi Biosciences Recent Development
10.11 Akeso, Inc
10.11.1 Akeso, Inc Company Information
10.11.2 Akeso, Inc Introduction and Business Overview
10.11.3 Akeso, Inc PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Akeso, Inc PD-1 and PD-L1 Drug Products Offered
10.11.5 Akeso, Inc Recent Development
10.12 BeiGene
10.12.1 BeiGene Company Information
10.12.2 BeiGene Introduction and Business Overview
10.12.3 BeiGene PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2024-2024)
10.12.4 BeiGene PD-1 and PD-L1 Drug Products Offered
10.12.5 BeiGene Recent Development
10.13 Innovent
10.13.1 Innovent Company Information
10.13.2 Innovent Introduction and Business Overview
10.13.3 Innovent PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2024-2024)
10.13.4 Innovent PD-1 and PD-L1 Drug Products Offered
10.13.5 Innovent Recent Development
10.14 Jiangsu Hengrui Medicine Co.,Ltd
10.14.1 Jiangsu Hengrui Medicine Co.,Ltd Company Information
10.14.2 Jiangsu Hengrui Medicine Co.,Ltd Introduction and Business Overview
10.14.3 Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2024-2024)
10.14.4 Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Products Offered
10.14.5 Jiangsu Hengrui Medicine Co.,Ltd Recent Development
10.15 Cstone
10.15.1 Cstone Company Information
10.15.2 Cstone Introduction and Business Overview
10.15.3 Cstone PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2024-2024)
10.15.4 Cstone PD-1 and PD-L1 Drug Products Offered
10.15.5 Cstone Recent Development
10.16 Henlius
10.16.1 Henlius Company Information
10.16.2 Henlius Introduction and Business Overview
10.16.3 Henlius PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2024-2024)
10.16.4 Henlius PD-1 and PD-L1 Drug Products Offered
10.16.5 Henlius Recent Development
10.17 Simcere Pharmaceutical Group Limited
10.17.1 Simcere Pharmaceutical Group Limited Company Information
10.17.2 Simcere Pharmaceutical Group Limited Introduction and Business Overview
10.17.3 Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Sales, Revenue and Gross Margin (2024-2024)
10.17.4 Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Products Offered
10.17.5 Simcere Pharmaceutical Group Limited Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 PD-1 and PD-L1 Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 PD-1 and PD-L1 Drug Industrial Chain Analysis
11.4 PD-1 and PD-L1 Drug Market Dynamics
11.4.1 PD-1 and PD-L1 Drug Industry Trends
11.4.2 PD-1 and PD-L1 Drug Market Drivers
11.4.3 PD-1 and PD-L1 Drug Market Challenges
11.4.4 PD-1 and PD-L1 Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 PD-1 and PD-L1 Drug Distributors
12.3 PD-1 and PD-L1 Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of PD-1 Monoclonal Antibody
Table 2. Major Company of PD-L1 Monoclonal Antibody
Table 3. Global PD-1 and PD-L1 Drug Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global PD-1 and PD-L1 Drug Sales by Type (2024-2024) & (K Units)
Table 5. Global PD-1 and PD-L1 Drug Sales Market Share in Volume by Type (2024-2024)
Table 6. Global PD-1 and PD-L1 Drug Sales by Type (2024-2024) & (US& Million)
Table 7. Global PD-1 and PD-L1 Drug Market Share in Value by Type (2024-2024)
Table 8. Global PD-1 and PD-L1 Drug Price by Type (2024-2024) & (US$/Unit)
Table 9. Global PD-1 and PD-L1 Drug Sales by Type (2024-2034) & (K Units)
Table 10. Global PD-1 and PD-L1 Drug Sales Market Share in Volume by Type (2024-2034)
Table 11. Global PD-1 and PD-L1 Drug Sales by Type (2024-2034) & (US$ Million)
Table 12. Global PD-1 and PD-L1 Drug Sales Market Share in Value by Type (2024-2034)
Table 13. Global PD-1 and PD-L1 Drug Price by Type (2024-2034) & (US$/Unit)
Table 14. North America PD-1 and PD-L1 Drug Sales by Type (2024-2024) & (K Units)
Table 15. North America PD-1 and PD-L1 Drug Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe PD-1 and PD-L1 Drug Sales (K Units) by Type (2024-2024)
Table 17. Europe PD-1 and PD-L1 Drug Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific PD-1 and PD-L1 Drug Sales (K Units) by Type (2024-2024)
Table 19. Asia-Pacific PD-1 and PD-L1 Drug Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America PD-1 and PD-L1 Drug Sales (K Units) by Type (2024-2024)
Table 21. Latin America PD-1 and PD-L1 Drug Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa PD-1 and PD-L1 Drug Sales (K Units) by Type (2024-2024)
Table 23. Middle East and Africa PD-1 and PD-L1 Drug Sales by Type (2024-2024) & (US$ Million)
Table 24. Global PD-1 and PD-L1 Drug Sales by Company (2024-2024) & (K Units)
Table 25. Global PD-1 and PD-L1 Drug Sales Share by Company (2024-2024)
Table 26. Global PD-1 and PD-L1 Drug Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global PD-1 and PD-L1 Drug Revenue Share by Company (2024-2024)
Table 28. Global Market PD-1 and PD-L1 Drug Price by Company (2024-2024) & (US$/Unit)
Table 29. Global PD-1 and PD-L1 Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global PD-1 and PD-L1 Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in PD-1 and PD-L1 Drug as of 2022)
Table 32. Date of Key Manufacturers Enter into PD-1 and PD-L1 Drug Market
Table 33. Key Manufacturers PD-1 and PD-L1 Drug Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global PD-1 and PD-L1 Drug Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global PD-1 and PD-L1 Drug Sales by Region (2024-2024) & (K Units)
Table 37. Global PD-1 and PD-L1 Drug Sales Market Share in Volume by Region (2024-2024)
Table 38. Global PD-1 and PD-L1 Drug Sales by Region (2024-2024) & (US$ Million)
Table 39. Global PD-1 and PD-L1 Drug Sales Market Share in Value by Region (2024-2024)
Table 40. Global PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 41. Global PD-1 and PD-L1 Drug Sales by Region (2024-2034) & (K Units)
Table 42. Global PD-1 and PD-L1 Drug Sales Market Share in Volume by Region (2024-2034)
Table 43. Global PD-1 and PD-L1 Drug Sales by Region (2024-2034) & (US$ Million)
Table 44. Global PD-1 and PD-L1 Drug Sales Market Share in Value by Region (2024-2034)
Table 45. Global PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 46. Global PD-1 and PD-L1 Drug Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global PD-1 and PD-L1 Drug Sales by Application (2024-2024) & (K Units)
Table 48. Global PD-1 and PD-L1 Drug Sales Market Share in Volume by Application (2024-2024)
Table 49. Global PD-1 and PD-L1 Drug Sales by Application (2024-2024) & (US$ Million)
Table 50. Global PD-1 and PD-L1 Drug Sales Market Share in Value by Application (2024-2024)
Table 51. Global PD-1 and PD-L1 Drug Price by Application (2024-2024) & (US$/Unit)
Table 52. Global PD-1 and PD-L1 Drug Sales by Application (2024-2034) & (K Units)
Table 53. Global PD-1 and PD-L1 Drug Sales Market Share in Volume by Application (2024-2034)
Table 54. Global PD-1 and PD-L1 Drug Sales by Application (2024-2034) & (US$ Million)
Table 55. Global PD-1 and PD-L1 Drug Sales Market Share in Value by Application (2024-2034)
Table 56. Global PD-1 and PD-L1 Drug Price by Application (2024-2034) & (US$/Unit)
Table 57. North America PD-1 and PD-L1 Drug Sales by Application (2024-2024) (K Units)
Table 58. North America PD-1 and PD-L1 Drug Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe PD-1 and PD-L1 Drug Sales by Application (2024-2024) (K Units)
Table 60. Europe PD-1 and PD-L1 Drug Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific PD-1 and PD-L1 Drug Sales by Application (2024-2024) (K Units)
Table 62. Asia-Pacific PD-1 and PD-L1 Drug Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America PD-1 and PD-L1 Drug Sales by Application (2024-2024) (K Units)
Table 64. Latin America PD-1 and PD-L1 Drug Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa PD-1 and PD-L1 Drug Sales by Application (2024-2024) (K Units)
Table 66. Middle East and Africa PD-1 and PD-L1 Drug Sales by Application (2024-2024) & (US$ Million)
Table 67. North America PD-1 and PD-L1 Drug Sales by Country (2024-2024) & (K Units)
Table 68. North America PD-1 and PD-L1 Drug Sales Market Share in Volume by Country (2024-2024)
Table 69. North America PD-1 and PD-L1 Drug Sales by Country (2024-2024) & (US$ Million)
Table 70. North America PD-1 and PD-L1 Drug Sales Market Share in Value by Country (2024-2024)
Table 71. North America PD-1 and PD-L1 Drug Sales by Country (2024-2034) & (K Units)
Table 72. North America PD-1 and PD-L1 Drug Sales Market Share in Volume by Country (2024-2034)
Table 73. North America PD-1 and PD-L1 Drug Sales by Country (2024-2034) & (US$ Million)
Table 74. North America PD-1 and PD-L1 Drug Sales Market Share in Value by Country (2024-2034)
Table 75. Europe PD-1 and PD-L1 Drug Sales by Country (2024-2024) & (K Units)
Table 76. Europe PD-1 and PD-L1 Drug Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe PD-1 and PD-L1 Drug Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe PD-1 and PD-L1 Drug Sales Market Share in Value by Country (2024-2024)
Table 79. Europe PD-1 and PD-L1 Drug Sales by Country (2024-2034) & (K Units)
Table 80. Europe PD-1 and PD-L1 Drug Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe PD-1 and PD-L1 Drug Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe PD-1 and PD-L1 Drug Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific PD-1 and PD-L1 Drug Sales by Region (2024-2024) & (K Units)
Table 84. Asia-Pacific PD-1 and PD-L1 Drug Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific PD-1 and PD-L1 Drug Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific PD-1 and PD-L1 Drug Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific PD-1 and PD-L1 Drug Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific PD-1 and PD-L1 Drug Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific PD-1 and PD-L1 Drug Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific PD-1 and PD-L1 Drug Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America PD-1 and PD-L1 Drug Sales by Country (2024-2024) & (K Units)
Table 92. Latin America PD-1 and PD-L1 Drug Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America PD-1 and PD-L1 Drug Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America PD-1 and PD-L1 Drug Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America PD-1 and PD-L1 Drug Sales by Country (2024-2034) & (K Units)
Table 96. Latin America PD-1 and PD-L1 Drug Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America PD-1 and PD-L1 Drug Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America PD-1 and PD-L1 Drug Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa PD-1 and PD-L1 Drug Sales by Country (2024-2024) & (K Units)
Table 100. Middle East and Africa PD-1 and PD-L1 Drug Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa PD-1 and PD-L1 Drug Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa PD-1 and PD-L1 Drug Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa PD-1 and PD-L1 Drug Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa PD-1 and PD-L1 Drug Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa PD-1 and PD-L1 Drug Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa PD-1 and PD-L1 Drug Sales Market Share in Value by Country (2024-2034)
Table 107. Bristol Myers Squibb Company Information
Table 108. Bristol Myers Squibb Introduction and Business Overview
Table 109. Bristol Myers Squibb PD-1 and PD-L1 Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 110. Bristol Myers Squibb PD-1 and PD-L1 Drug Product
Table 111. Bristol Myers Squibb Recent Development
Table 112. Merck & Co., Inc. Company Information
Table 113. Merck & Co., Inc. Introduction and Business Overview
Table 114. Merck & Co., Inc. PD-1 and PD-L1 Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 115. Merck & Co., Inc. PD-1 and PD-L1 Drug Product
Table 116. Merck & Co., Inc. Recent Development
Table 117. F. Hoffmann -La Roche Ltd Company Information
Table 118. F. Hoffmann -La Roche Ltd Introduction and Business Overview
Table 119. F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 120. F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Product
Table 121. F. Hoffmann -La Roche Ltd Recent Development
Table 122. AstraZeneca Company Information
Table 123. AstraZeneca Introduction and Business Overview
Table 124. AstraZeneca PD-1 and PD-L1 Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 125. AstraZeneca PD-1 and PD-L1 Drug Product
Table 126. AstraZeneca Recent Development
Table 127. Sanofi Company Information
Table 128. Sanofi Introduction and Business Overview
Table 129. Sanofi PD-1 and PD-L1 Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 130. Sanofi PD-1 and PD-L1 Drug Product
Table 131. Sanofi Recent Development
Table 132. Pfizer Inc Company Information
Table 133. Pfizer Inc Introduction and Business Overview
Table 134. Pfizer Inc PD-1 and PD-L1 Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 135. Pfizer Inc PD-1 and PD-L1 Drug Product
Table 136. Pfizer Inc Recent Development
Table 137. Lilly Company Information
Table 138. Lilly Introduction and Business Overview
Table 139. Lilly PD-1 and PD-L1 Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 140. Lilly PD-1 and PD-L1 Drug Product
Table 141. Lilly Recent Development
Table 142. Novartis AG Company Information
Table 143. Novartis AG Introduction and Business Overview
Table 144. Novartis AG PD-1 and PD-L1 Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 145. Novartis AG PD-1 and PD-L1 Drug Product
Table 146. Novartis AG Recent Development
Table 147. GSK Company Information
Table 148. GSK Introduction and Business Overview
Table 149. GSK PD-1 and PD-L1 Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 150. GSK PD-1 and PD-L1 Drug Product
Table 151. GSK Recent Development
Table 152. Junshi Biosciences Company Information
Table 153. Junshi Biosciences Introduction and Business Overview
Table 154. Junshi Biosciences PD-1 and PD-L1 Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 155. Junshi Biosciences PD-1 and PD-L1 Drug Product
Table 156. Junshi Biosciences Recent Development
Table 157. Akeso, Inc Company Information
Table 158. Akeso, Inc Introduction and Business Overview
Table 159. Akeso, Inc PD-1 and PD-L1 Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 160. Akeso, Inc PD-1 and PD-L1 Drug Product
Table 161. Akeso, Inc Recent Development
Table 162. BeiGene Company Information
Table 163. BeiGene Introduction and Business Overview
Table 164. BeiGene PD-1 and PD-L1 Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 165. BeiGene PD-1 and PD-L1 Drug Product
Table 166. BeiGene Recent Development
Table 167. Innovent Company Information
Table 168. Innovent Introduction and Business Overview
Table 169. Innovent PD-1 and PD-L1 Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 170. Innovent PD-1 and PD-L1 Drug Product
Table 171. Innovent Recent Development
Table 172. Jiangsu Hengrui Medicine Co.,Ltd Company Information
Table 173. Jiangsu Hengrui Medicine Co.,Ltd Introduction and Business Overview
Table 174. Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 175. Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Product
Table 176. Jiangsu Hengrui Medicine Co.,Ltd Recent Development
Table 177. Cstone Company Information
Table 178. Cstone Introduction and Business Overview
Table 179. Cstone PD-1 and PD-L1 Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 180. Cstone PD-1 and PD-L1 Drug Product
Table 181. Cstone Recent Development
Table 182. Henlius Company Information
Table 183. Henlius Introduction and Business Overview
Table 184. Henlius PD-1 and PD-L1 Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 185. Henlius PD-1 and PD-L1 Drug Product
Table 186. Henlius Recent Development
Table 187. Simcere Pharmaceutical Group Limited Company Information
Table 188. Simcere Pharmaceutical Group Limited Introduction and Business Overview
Table 189. Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 190. Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Product
Table 191. Simcere Pharmaceutical Group Limited Recent Development
Table 192. Key Raw Materials Lists
Table 193. Raw Materials Key Suppliers Lists
Table 194. PD-1 and PD-L1 Drug Market Trends
Table 195. PD-1 and PD-L1 Drug Market Drivers
Table 196. PD-1 and PD-L1 Drug Market Challenges
Table 197. PD-1 and PD-L1 Drug Market Restraints
Table 198. PD-1 and PD-L1 Drug Distributors List
Table 199. PD-1 and PD-L1 Drug Downstream Customers
Table 200. Research Programs/Design for This Report
Table 201. Key Data Information from Secondary Sources
Table 202. Key Data Information from Primary Sources
List of Figures
Figure 1. PD-1 and PD-L1 Drug Product Picture
Figure 2. Global PD-1 and PD-L1 Drug Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global PD-1 and PD-L1 Drug Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global PD-1 and PD-L1 Drug Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of PD-1 Monoclonal Antibody
Figure 6. Global PD-1 Monoclonal Antibody Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of PD-L1 Monoclonal Antibody
Figure 8. Global PD-L1 Monoclonal Antibody Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Global PD-1 and PD-L1 Drug Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global PD-1 and PD-L1 Drug Sales Market Share by Type in 2022 & 2034
Figure 11. North America PD-1 and PD-L1 Drug Sales Market Share in Volume by Type in 2022
Figure 12. North America PD-1 and PD-L1 Drug Sales Market Share in Value by Type in 2022
Figure 13. Europe PD-1 and PD-L1 Drug Sales Market Share in Volume by Type in 2022
Figure 14. Europe PD-1 and PD-L1 Drug Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific PD-1 and PD-L1 Drug Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific PD-1 and PD-L1 Drug Sales Market Share in Value by Type in 2022
Figure 17. Latin America PD-1 and PD-L1 Drug Sales Market Share in Volume by Type in 2022
Figure 18. Latin America PD-1 and PD-L1 Drug Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa PD-1 and PD-L1 Drug Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa PD-1 and PD-L1 Drug Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by PD-1 and PD-L1 Drug Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by PD-1 and PD-L1 Drug Revenue in 2022
Figure 23. PD-1 and PD-L1 Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Liver Cancer
Figure 25. Global Liver Cancer Sales YoY Growth (2024-2034) & (K Units)
Figure 26. Product Picture of Esophageal Cancer
Figure 27. Global Esophageal Cancer Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Product Picture of Nasal Cancer
Figure 29. Global Nasal Cancer Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Product Picture of Stomach Cancer
Figure 31. Global Stomach Cancer Sales YoY Growth (2024-2034) & (K Units)
Figure 32. Product Picture of Other
Figure 33. Global Other Sales YoY Growth (2024-2034) & (K Units)
Figure 34. Global PD-1 and PD-L1 Drug Sales by Application (2024-2034) & (US$ Million)
Figure 35. Global PD-1 and PD-L1 Drug Sales Market Share by Application in 2022 & 2034
Figure 36. North America PD-1 and PD-L1 Drug Sales Market Share in Volume by Application in 2022
Figure 37. North America PD-1 and PD-L1 Drug Sales Market Share in Value by Application in 2022
Figure 38. Europe PD-1 and PD-L1 Drug Sales Market Share in Volume by Application in 2022
Figure 39. Europe PD-1 and PD-L1 Drug Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific PD-1 and PD-L1 Drug Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific PD-1 and PD-L1 Drug Sales Market Share in Value by Application in 2022
Figure 42. Latin America PD-1 and PD-L1 Drug Sales Market Share in Volume by Application in 2022
Figure 43. Latin America PD-1 and PD-L1 Drug Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa PD-1 and PD-L1 Drug Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. PD-1 and PD-L1 Drug Manufacturing Cost Structure
Figure 47. PD-1 and PD-L1 Drug Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed